Ruyi Xue

机构：Sun Yat-sen University, Fudan University, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University

发表论文 22 篇 · 总被引 189 次 · h-index 7

代表论文

• CD36-BATF2\MYB Axis Predicts Anti-PD-1 Immunotherapy Response in Gastric Cancer (2023 · International Journal of Biological Sciences · 被引 29)
• Prp19 facilitates invasion of hepatocellular carcinoma via p38 mitogen-activated protein kinase/Twist1 pathway (2016 · Oncotarget · 被引 27)
• Nine susceptibility loci for hepatitis B virus-related hepatocellular carcinoma identified by a pilot two-stage genome-wide association study (2015 · Oncology Letters · 被引 24)
• circRanGAP1/miR-27b-3p/NRAS Axis may promote the progression of hepatocellular Carcinoma (2022 · Experimental Hematology and Oncology · 被引 18)
• GSDME-mediated pyroptosis contributes to chemotherapy-induced platelet hyperactivity and thrombotic potential (2024 · Blood · 被引 15)
• Efficient gene delivery by multifunctional star poly (β-amino ester)s into difficult-to-transfect macrophages for M1 polarization (2024 · Journal of Controlled Release · 被引 15)